SubsidieMeestersVISUALIZACIÓN DE BIOPOTENCIALES PARA EQUIPOS CARDIOLÓGICOS
VR-CARDIO is an innovative medical tool that uses AR/VR for precise visualization and diagnosis of arrhythmia, enhancing cardiac ablation speed and accuracy.
Projectdetails
Introduction
VR-CARDIO is a unique medical tool for visualization and diagnosis of arrhythmia. The arrhythmia is an alteration of the heart rhythm. It occurs when the electrical impulses that coordinate the beats do not work properly.
Functionality
VR-CARDIO allows a reliable and validated estimation of electrocardiogram cardiac and transmembrane action potentials that enable detecting with absolute precision the origin and mechanism of heart disease.
Advantages
Instead of using only electrocardiograms captured by catheters, as is done with current Cardiac Navigation Systems (CNS), VR-CARDIO enables a revolutionary bioelectrical navigation of the cardiac system in a precise and safe way.
Key Benefits
- Comprehensive Coverage: It navigates the entire volume of the cardiac cavity.
- Increased Efficiency: The cardiac ablation process is infinitely faster.
- Real-Time Monitoring: The electrophysiologist is constantly watching the development of the electric impulse throughout the heart.
Visualization Technology
The tool provides 360º visualization in augmented reality (AR) and/or virtual reality (VR).
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 3.589.741 |
Tijdlijn
| Startdatum | 1-9-2022 |
| Einddatum | 30-6-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SPIKA TECH SLpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Using CARDIac simulations to run in-silicO clinical TRIALSThis project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials. | ERC STG | € 1.499.423 | 2022 | Details |
Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular DiseasesThe project aims to revolutionize cardiovascular disease diagnosis and treatment by developing a fast, automated cardiac MRI system for comprehensive, one-click imaging and analysis. | ERC STG | € 1.498.529 | 2023 | Details |
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatmentsThis project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease. | ERC STG | € 1.500.000 | 2024 | Details |
Cardiac-AIHet project ontwikkelt een prototype voor continue, niet-invasieve bloeddrukmeting met PPG, gericht op het voorkomen van cardiovasculaire ziekten bij pre-operatieve en revaliderende patiënten. | MIT R&D Samenwerking | € 179.806 | 2022 | Details |
Using CARDIac simulations to run in-silicO clinical TRIALS
This project aims to develop a GPU-accelerated computational platform for simulating cardiac pathologies and device responses, integrating uncertainty quantification to enhance in-silico clinical trials.
Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular Diseases
The project aims to revolutionize cardiovascular disease diagnosis and treatment by developing a fast, automated cardiac MRI system for comprehensive, one-click imaging and analysis.
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments
This project aims to understand cardiac electroporation mechanisms to develop methods for effective irreversible and reversible treatments for atrial fibrillation and ischemic heart disease.
Cardiac-AI
Het project ontwikkelt een prototype voor continue, niet-invasieve bloeddrukmeting met PPG, gericht op het voorkomen van cardiovasculaire ziekten bij pre-operatieve en revaliderende patiënten.